









Mercado
/
Acciones
/
nasdaq-teva
/

Teva Pharmaceutical Industries Ltd

TEVA

34.690USD

-0.140-0.40%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

39.80BCap. mercado

28.17P/E TTM



Teva Pharmaceutical Industries Ltd

34.690

-0.140-0.40%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Teva Pharmaceutical Industries Ltd Compañía

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Información de Teva Pharmaceutical Industries Ltd



Símbolo de cotizaciónTEVA

Nombre de la empresaTeva Pharmaceutical Industries Ltd

Fecha de salida a bolsaFeb 06, 2087

Director ejecutivoFrancis (Richard D)

Número de empleados33892

Tipo de seguridadDepository Receipt

Fin del año fiscalFeb 06

Dirección124 Dvora Hanevi'a St.

CiudadTEL AVIV-YAFO

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísIsrael

Código postal6944020

Teléfono97239148213

Sitio Webhttps://www.tevapharm.com/

Símbolo de cotizaciónTEVA

Fecha de salida a bolsaFeb 06, 2087

Director ejecutivoFrancis (Richard D)

Ejecutivos de Teva Pharmaceutical Industries Ltd



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Amir Elstein

Independent Director

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

Ms. Rosemary A. (Rose) Crane

Independent Director

Mr. Gerald M. (Jerry) Lieberman

Independent Director

Mr. Richard Daniell

Executive Vice President - European Commercial

Mr. Roberto A. Mignone

Independent Director

Dr. Perry D. Nisen, M.D., Ph.D.

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Amir Elstein

Independent Director

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

Ms. Rosemary A. (Rose) Crane

Independent Director

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

Otro

458.00M

10.22%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

2.48B

55.40%

Europe

1.24B

27.57%

International Markets

558.00M

12.46%

Other

205.00M

4.58%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

Otro

458.00M

10.22%

Estadísticas de accionistas

Actualizado: dom., 11 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

Harel Insurance Investments and Financial Services Ltd

3.91%

Phoenix Investment and Finances Ltd

3.57%

Menora Mivtachim Insurance Ltd.

3.38%

Migdal Insurance and Financial Holdings Ltd

3.25%

BlackRock Institutional Trust Company, N.A.

3.04%

Otro

82.85%

Accionistas

Proporción

Harel Insurance Investments and Financial Services Ltd

3.91%

Phoenix Investment and Finances Ltd

3.57%

Menora Mivtachim Insurance Ltd.

3.38%

Migdal Insurance and Financial Holdings Ltd

3.25%

BlackRock Institutional Trust Company, N.A.

3.04%

Otro

82.85%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

23.09%

Investment Advisor/Hedge Fund

12.52%

Hedge Fund

10.41%

Insurance Company

6.65%

Research Firm

2.35%

Family Office

1.86%

Pension Fund

1.56%

Bank and Trust

0.85%

Sovereign Wealth Fund

0.24%

Otro

40.48%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1165

666.08M

57.93%

-136.04M

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Harel Insurance Investments and Financial Services Ltd

37.70M

3.29%

+4.31M

+12.90%

Sep 30, 2025

Phoenix Investment and Finances Ltd

41.30M

3.6%

+3.53M

+9.36%

Sep 30, 2025

Menora Mivtachim Insurance Ltd.

38.92M

3.39%

-18.47M

-32.19%

Sep 30, 2025

Migdal Insurance and Financial Holdings Ltd

32.58M

2.84%

+3.90M

+13.58%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

34.92M

3.04%

+1.03M

+3.04%

Sep 30, 2025

Clal Insurance Enterprises Holdings Ltd.

31.49M

2.74%

-876.00K

-2.71%

Sep 30, 2025

Lingotto Investment Management LLP

28.59M

2.49%

+431.87K

+1.53%

Sep 30, 2025

Rubric Capital Management LP

24.65M

2.15%

-1.35M

-5.19%

Sep 30, 2025

PointState Capital LP

20.71M

1.81%

Sep 30, 2025

Fidelity Management & Research Company LLC

20.19M

1.76%

-30.45M

-60.13%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

iShares MSCI Israel ETF

7.76%

VanEck Israel ETF

7.5%

VanEck Pharmaceutical ETF

3.79%

First Trust WCM Developing World Equity ETF

3.16%

First Trust WCM International Equity ETF

2.64%

ARK Israel Innovative Technology ETF

1.81%

WealthTrust DBS Long Term Growth ETF

1.42%

WisdomTree International Multifactor Fund

0.77%

iShares Health Innovation Active ETF

0.69%

iShares MSCI Intl Value Factor ETF

0.46%

iShares MSCI Israel ETF

Proporción7.76%

VanEck Israel ETF

Proporción7.5%

VanEck Pharmaceutical ETF

Proporción3.79%

First Trust WCM Developing World Equity ETF

Proporción3.16%

First Trust WCM International Equity ETF

Proporción2.64%

ARK Israel Innovative Technology ETF

Proporción1.81%

WealthTrust DBS Long Term Growth ETF

Proporción1.42%

WisdomTree International Multifactor Fund

Proporción0.77%

iShares Health Innovation Active ETF

Proporción0.69%

iShares MSCI Intl Value Factor ETF

Proporción0.46%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

